BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26179504)

  • 1. Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial.
    El Messaoudi S; Nederlof R; Zuurbier CJ; van Swieten HA; Pickkers P; Noyez L; Dieker HJ; Coenen MJ; Donders AR; Vos A; Rongen GA; Riksen NP
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):615-23. PubMed ID: 26179504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dipyridamole on myocardial reperfusion injury: A double-blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery.
    El Messaoudi S; Wouters CW; van Swieten HA; Pickkers P; Noyez L; Kievit PC; Abbink EJ; Rasing-Hoogveld A; Bouw TP; Peters JG; Coenen MJ; Donders AR; Riksen NP; Rongen GA
    Clin Pharmacol Ther; 2016 Apr; 99(4):381-9. PubMed ID: 25773594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
    Petrie JR; Chaturvedi N; Ford I; Brouwers MCGJ; Greenlaw N; Tillin T; Hramiak I; Hughes AD; Jenkins AJ; Klein BEK; Klein R; Ooi TC; Rossing P; Stehouwer CDA; Sattar N; Colhoun HM;
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):597-609. PubMed ID: 28615149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate hyperoxic versus near-physiological oxygen targets during and after coronary artery bypass surgery: a randomised controlled trial.
    Smit B; Smulders YM; de Waard MC; Boer C; Vonk AB; Veerhoek D; Kamminga S; de Grooth HJ; García-Vallejo JJ; Musters RJ; Girbes AR; Oudemans-van Straaten HM; Spoelstra-de Man AM
    Crit Care; 2016 Mar; 20():55. PubMed ID: 26968380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial.
    Alam SR; Lewis SC; Zamvar V; Pessotto R; Dweck MR; Krishan A; Goodman K; Oatey K; Harkess R; Milne L; Thomas S; Mills NM; Moore C; Semple S; Wiedow O; Stirrat C; Mirsadraee S; Newby DE; Henriksen PA
    Heart; 2015 Oct; 101(20):1639-45. PubMed ID: 26310261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.
    ; Alexander JH; Emery RW; Carrier M; Ellis SJ; Mehta RH; Hasselblad V; Menasche P; Khalil A; Cote R; Bennett-Guerrero E; Mack MJ; Schuler G; Harrington RA; Tardif JC
    JAMA; 2008 Apr; 299(15):1777-87. PubMed ID: 18381567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.
    Thielmann M; Kottenberg E; Kleinbongard P; Wendt D; Gedik N; Pasa S; Price V; Tsagakis K; Neuhäuser M; Peters J; Jakob H; Heusch G
    Lancet; 2013 Aug; 382(9892):597-604. PubMed ID: 23953384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
    Viney NJ; van Capelleveen JC; Geary RS; Xia S; Tami JA; Yu RZ; Marcovina SM; Hughes SG; Graham MJ; Crooke RM; Crooke ST; Witztum JL; Stroes ES; Tsimikas S
    Lancet; 2016 Nov; 388(10057):2239-2253. PubMed ID: 27665230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial.
    Baradari AG; Emami Zeydi A; Aarabi M; Ghafari R
    Pak J Biol Sci; 2011 Dec; 14(23):1047-54. PubMed ID: 22590838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
    Preiss D; Lloyd SM; Ford I; McMurray JJ; Holman RR; Welsh P; Fisher M; Packard CJ; Sattar N
    Lancet Diabetes Endocrinol; 2014 Feb; 2(2):116-24. PubMed ID: 24622715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial.
    Besch G; Perrotti A; Salomon du Mont L; Puyraveau M; Ben-Said X; Baltres M; Barrucand B; Flicoteaux G; Vettoretti L; Samain E; Chocron S; Pili-Floury S
    Cardiovasc Diabetol; 2018 Nov; 17(1):140. PubMed ID: 30384842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
    Budeus M; Hennersdorf M; Perings S; Röhlen S; Schnitzler S; Felix O; Reimert K; Feindt P; Gams E; Lehmann N; Wieneke H; Sack S; Erbel R; Perings C
    Eur Heart J; 2006 Jul; 27(13):1584-91. PubMed ID: 16760210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effect of sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double-blind randomised study.
    Soro M; Gallego L; Silva V; Ballester MT; Lloréns J; Alvariño A; García-Perez ML; Pastor E; Aguilar G; Martí FJ; Carratala A; Belda FJ
    Eur J Anaesthesiol; 2012 Dec; 29(12):561-9. PubMed ID: 22965457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
    Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
    JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial.
    Ludman AJ; Hausenloy DJ; Babu G; Hasleton J; Venugopal V; Boston-Griffiths E; Yap J; Lawrence D; Hayward M; Kolvekar S; Bognolo G; Rees P; Yellon DM
    Basic Res Cardiol; 2011 Nov; 106(6):1387-95. PubMed ID: 21833652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.